NXGL

STEFANSKY DAVID

Known title: DirectorCIK: 0001320581

STEFANSKY DAVID's purchase track record

How the stock did after each of STEFANSKY DAVID's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
7
of 7 since December 27, 2021
Stock higher 6 months later
14%
3 months: 43%
Median 6-month return
-17.2%
3 months: -3.8%
Beat the S&P 500
14%
median -13.5% vs. index
PurchaseStockAmount3 months6 months
6/7/2023NXGL$7K+1.2%-18.4%
5/30/2023NXGL$17K-3.8%-25.1%
12/12/2022NXGL$19K+1.1%+90.3%
8/25/2022NXGL$17K-29.2%-15.1%
8/15/2022NXGL$10K-29.6%-17.2%
6/24/2022NXGL$5K+1.9%-15.0%
12/27/2021NXGL$50K-40.0%-42.5%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 7, 2026

NXGL Listed Among 12 Health Care Stocks Moving in Pre‑Market Session. NXGL was one of 12 health‑care stocks that moved in Wednesday’s pre‑market session. The move reflects short‑term interest in the sector. The stock is trading near its 52‑week low and has a low RSI, which may have contributed to the pre‑market activity.

this person other insiders at NXGL

Transaction History

NXGL▲ Buy$2K
NXGL▲ Buy$5K
NXGL▲ Buy$5K
NXGL▲ Buy$13K
NXGL▲ Buy$8K
NXGL▲ Buy$11K
NXGL▲ Buy$8K
NXGL▲ Buy$9K
NXGL▲ Buy$4K
NXGL▲ Buy$5K
NXGL▲ Buy$5K
NXGL▲ Buy$50K

We use analytics to understand how market-wall is used. No personal data is sold.